William Jones's most recent trade in Apogee Therapeutics Inc. was a trade of 14,461 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apogee Therapeutics Inc. | William Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 14,461 | 14,461 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | William Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. | 04 Jun 2025 | 19,357 | 173,130 (0%) | 0% | 3.5 | 67,750 | Common Stock |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 19,357 | 0 | - | - | Warrant (Right to Buy) | |
| Annexon Inc | William Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 88,000 | 88,000 | - | - | Stock Option (Right to Buy) | |
| NewAmsterdam Pharma Compan... | William Jones | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 43,000 | 43,000 | - | - | Ordinary Shares | |
| NewAmsterdam Pharma Compan... | William Jones | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 200,000 | 200,000 | - | - | Option (right to buy) | |
| Corvus Pharmaceuticals Inc | Jones William Benton | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | William B.J. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,370 | 10,370 | - | - | Stock Option (Right to Buy) | |
| Linkbancorp Inc | William L. Jones | Director | 23 May 2024 | 2,000 | 14,377 | - | 0 | Common Stock | ||
| Linkbancorp Inc | William L. Jones | Director | 16 May 2024 | 2,500 | 12,377 | - | 6.5 | 16,250 | Common Stock | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 06 May 2024 | 20,000 | 153,773 (0%) | 0% | 1.7 | 34,624 | Common Stock |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 May 2024 | 19,357 | 19,357 | - | - | Warrant (Right to Buy) | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Thor Industries, Inc. | William R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2023 | 1,409 | 12,902 (0%) | 0% | 0 | Common Stock | |
| Linkbancorp Inc | William L. Jones | Director | 31 Aug 2023 | 2,000 | 9,877 | - | 0 | Common Stock | ||
| Akili Inc | William B.J. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.74 per share. | 20 Feb 2023 | 954 | 26,941 (0%) | 0% | 36.7 | 35,050 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2023 | 954 | 27,895 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2023 | 505 | 4,383 | - | - | Restricted Stock Units | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2023 | 449 | 11,691 | - | - | Restricted Stock Units | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 8,251 | 24,795 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.67 per share. | 03 Feb 2023 | 3,045 | 21,750 (0%) | 0% | 40.7 | 123,840 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 2,053 | 23,803 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 1,369 | 24,463 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 1,048 | 25,038 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.67 per share. | 03 Feb 2023 | 709 | 23,094 (0%) | 0% | 40.7 | 28,835 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 700 | 25,376 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.67 per share. | 03 Feb 2023 | 473 | 23,990 (0%) | 0% | 40.7 | 19,237 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.67 per share. | 03 Feb 2023 | 362 | 24,676 (0%) | 0% | 40.7 | 14,723 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.67 per share. | 03 Feb 2023 | 242 | 25,134 (0%) | 0% | 40.7 | 9,842 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 18,371 | 18,371 | - | - | Restricted Stock Units | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 20 Dec 2022 | 20,000 | 133,773 (0%) | 0% | 0.8 | 15,800 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.60 per share. | 20 Nov 2022 | 7,195 | 16,544 (0%) | 0% | 35.6 | 256,142 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2022 | 7,195 | 20,000 | - | - | Restricted Stock Units | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2022 | 7,195 | 23,739 (0%) | 0% | 0 | Common Stock | |
| Akili Inc | William B.J. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Thor Industries, Inc. | William R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2022 | 1,658 | 11,493 (0%) | 0% | 0 | Common Stock | |
| Linkbancorp Inc | William L. Jones | Director | 14 Sep 2022 | 571 | 7,877 | - | 7.5 | 4,283 | Common Stock | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Alto Ingredients Inc | William L. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 26,965 | 210,353 (0%) | 0% | 0 | Common Stock | |
| Biogen | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 2,145 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 168 | 4,400 | - | - | Restricted Stock Units | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.45 per share. | 20 May 2022 | 168 | 3,739 (0%) | 0% | 38.5 | 6,460 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 168 | 3,907 (0%) | 0% | 0 | Common Stock | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 34 | 35,781 | - | - | Phantom Shares | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 3,933 | 3,933 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.15 per share. | 04 Feb 2022 | 1,475 | 2,458 (0%) | 0% | 62.1 | 91,671 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 880 | 3,338 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 587 | 3,621 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.15 per share. | 04 Feb 2022 | 304 | 3,034 (0%) | 0% | 62.2 | 18,894 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.15 per share. | 04 Feb 2022 | 202 | 3,419 (0%) | 0% | 62.1 | 12,554 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 12,990 | 12,990 | - | - | Restricted Stock Units | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 5,845 | 5,845 | - | - | Restricted Stock Units | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 94 | 35,461 | - | - | Phantom Shares | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Sale of securities on an exchange or to another person at price $ 69.16 per share. | 23 Nov 2021 | 12,885 | 0 (0%) | 0% | 69.2 | 891,149 | Common Stock |
| Thor Industries, Inc. | William R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 1,615 | 9,835 (0%) | 0% | 0 | Common Stock | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 99 | 35,068 | - | - | Phantom Shares | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Biogen | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 775 (0%) | 0% | 0 | Common Stock | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 93 | 34,679 | - | - | Phantom Shares | |
| Alto Ingredients Inc | William L. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 23,867 | 183,388 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 4,888 | 4,888 | - | - | Restricted Stock Units | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 833 | 4,983 (0%) | 0% | 0 | Common Stock | |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 94 | 34,311 | - | - | Phantom Shares | |
| Alto Ingredients Inc | William L. Jones | Director | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 17 Mar 2021 | 20,000 | 159,521 (0%) | 0% | 6.0 | 119,600 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 1,344 | 1,344 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.77 per share. | 26 Feb 2021 | 552 | 792 (0%) | 0% | 39.8 | 21,953 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 120 | 38,845 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 57 | 18,387 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 39 | 12,730 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 97.08 per share. | 08 Feb 2021 | 89,575 | 164,522 (0%) | 0% | 97.1 | 8,695,941 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.89 per share. | 08 Feb 2021 | 89,575 | 254,097 (0%) | 0% | 66.9 | 5,991,672 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 89,575 | 0 | - | - | Options | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 93.36 per share. | 29 Jan 2021 | 21,926 | 167,596 (0%) | 0% | 93.4 | 2,047,011 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 93.19 per share. | 29 Jan 2021 | 3,074 | 164,522 (0%) | 0% | 93.2 | 286,466 | Common Stock |
| DBA Sempra | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 100 | 33,930 | - | - | Phantom Shares | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Alto Ingredients Inc | William L. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 26,152 | 179,521 (0%) | 0% | 0 | Common Stock | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.78 per share. | 01 Dec 2020 | 51 | 189,526,749 (277%) | 0% | 81.8 | 4,171 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 51 | 12,691 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 40 | 0 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 80.70 per share. | 01 Dec 2020 | 40 | 189,492 (0%) | 0% | 80.7 | 3,228 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.41 per share. | 01 Dec 2020 | 37 | 189,540 (0%) | 0% | 81.4 | 3,012 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 37 | 18,330 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.50 per share. | 01 Dec 2020 | 24 | 189,502 (0%) | 0% | 80.5 | 1,932 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.50 per share. | 01 Dec 2020 | 18 | 189,522 (0%) | 0% | 80.5 | 1,449 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.50 per share. | 01 Dec 2020 | 18 | 189,474 (0%) | 0% | 80.5 | 1,449 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 112 | 18,367 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 103 | 12,743 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 40 | 40 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 9,781 | 193,820 (0%) | 0% | - | Common Stock | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 9,781 | 0 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.55 per share. | 20 Nov 2020 | 4,368 | 189,452 (0%) | 0% | 80.5 | 351,842 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2020 | 12,638 | 189,683 (0%) | 0% | - | Common Stock | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2020 | 12,638 | 12,639 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2020 | 9,126 | 18,255 | - | - | Restricted Stock Units | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2020 | 9,126 | 181,334 (0%) | 0% | - | Common Stock | |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.19 per share. | 18 Nov 2020 | 5,644 | 184,039 (0%) | 0% | 80.2 | 452,592 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.23 per share. | 18 Nov 2020 | 4,290 | 177,044 (0%) | 0% | 79.2 | 339,897 | Common Stock |
| Oshkosh Corp | William R. Jones | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2020 | 38,725 | 38,725 | - | - | Restricted Stock Units |